EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS139-34396 
Organism
Homo sapiens 
Tissue/cell
Myotube 
Coordinate
chr21:40759780-40761840 
TF binding sites/motifs
Number: 25             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
CTCFMA0139.1chr21:40760668-40760687GGGCGCCACCTGGCGGTCA-6.95
EWSR1-FLI1MA0149.1chr21:40760988-40761006CCTTCCTTCCTTCCTTCC-10.83
EWSR1-FLI1MA0149.1chr21:40761008-40761026CCTCCCTTCCTCCCTTCT-6.66
EWSR1-FLI1MA0149.1chr21:40761016-40761034CCTCCCTTCTTCCCTTCC-6.68
EWSR1-FLI1MA0149.1chr21:40761004-40761022CCTCCCTCCCTTCCTCCC-6.92
EWSR1-FLI1MA0149.1chr21:40761024-40761042CTTCCCTTCCTTCCTTCA-6.98
EWSR1-FLI1MA0149.1chr21:40761012-40761030CCTTCCTCCCTTCTTCCC-7.1
EWSR1-FLI1MA0149.1chr21:40760976-40760994CCTGCCTGCCTGCCTTCC-7.45
EWSR1-FLI1MA0149.1chr21:40761020-40761038CCTTCTTCCCTTCCTTCC-8.05
EWSR1-FLI1MA0149.1chr21:40760996-40761014CCTTCCTTCCTCCCTCCC-8.32
EWSR1-FLI1MA0149.1chr21:40761000-40761018CCTTCCTCCCTCCCTTCC-8.62
EWSR1-FLI1MA0149.1chr21:40760980-40760998CCTGCCTGCCTTCCTTCC-9.02
EWSR1-FLI1MA0149.1chr21:40760992-40761010CCTTCCTTCCTTCCTCCC-9.47
EWSR1-FLI1MA0149.1chr21:40760984-40761002CCTGCCTTCCTTCCTTCC-9.99
MEF2CMA0497.1chr21:40759866-40759881ATCTATTTTTAAAAT-6.19
ZNF263MA0528.1chr21:40760995-40761016TCCTTCCTTCCTCCCTCCCTT-6.09
ZNF263MA0528.1chr21:40761023-40761044TCTTCCCTTCCTTCCTTCACC-6.22
ZNF263MA0528.1chr21:40761007-40761028CCCTCCCTTCCTCCCTTCTTC-6.86
ZNF263MA0528.1chr21:40761020-40761041CCTTCTTCCCTTCCTTCCTTC-6.87
ZNF263MA0528.1chr21:40761016-40761037CCTCCCTTCTTCCCTTCCTTC-6.92
ZNF263MA0528.1chr21:40760999-40761020TCCTTCCTCCCTCCCTTCCTC-6
ZNF263MA0528.1chr21:40760991-40761012TCCTTCCTTCCTTCCTCCCTC-7.08
ZNF263MA0528.1chr21:40761003-40761024TCCTCCCTCCCTTCCTCCCTT-7.37
ZNF263MA0528.1chr21:40760988-40761009CCTTCCTTCCTTCCTTCCTCC-7.42
ZNF263MA0528.1chr21:40761000-40761021CCTTCCTCCCTCCCTTCCTCC-8.12
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr214076124040761354
chr214076150640761663
Enhancer Sequence
TGTAAGCTGG AAGGGGGAGG GGGGGGGATC TGATTTATTG TGTGCCAGGC ACACTTTAGA 60
TACACTATAA CATTTCGTCT TTATTAATCT ATTTTTAAAA TTTCGAAACA AACACAAATG 120
TGCAGAAAAG TTATATACAG TCAATACCGA TAACTGATTT TGTTTCCTGA ACCATTTGGA 180
AGTTGTCAAC CCAAACCCCC TCATTCCGAG ATACTTTGGT ATTCAAAAGA ATCTTGGGGG 240
CCGGGCACAG TGGCTCACGC CTTTAATCCC AGCACTTTGG GAGGCCGAGG CTGGCGGATC 300
GCTTGAGCTC AGGAGTTCAC TGGCAACATA GTGAAACCGT GTGTCTACTA AAACTAAAAA 360
AAAATTAGTC GAGTGTGGTG GTGCAGGCCT GTAGTCCCAG ATGCTCAGGA GGCTCAGGTG 420
GGAGTATCGC TTGAGCCCAG GAAGTCGAGG TTGCAGTGAG CCGAGATCTA ATGCAGGCGT 480
CAAGTACGTT ACCACGATCT GATCCTCAGA CCCCATGCAG GTTCCCCACG TTTCGCAGTA 540
ATGTCCTTAA CAGGGAAAGG ACCCAGTTCG GAATCATGCA TTGCATTTCC CGGCCTCTAG 600
CCTCCTGTCT GGAGGAGTTT CCCAGTCTTC CCTTGACTTT CATGGCTGTC ATTTGTGGGT 660
GTCAGAGGCC AGTGATTTCG CAGAAGGGAC GCCTACTGGC ATGTCTGATA CTTGGTAGGG 720
ATTTCTGAGA GGCAGTGCTG TGTTCTCATT GTGTCTCATC CGCTGGTGTG GGACTGGGAT 780
TTGGGGATGT TCGCTGATCC CTTGGGGTAG GTGCCAGAGG CGCCACTGAG GGATCTGGTC 840
TTGGGGCGCC CGCGCAGTCC TTGGACTAGG CCTTCCCGGC AGATCTGCGG GCGCCACCTG 900
GCGGTCACTG CCGACTCCTC CGTTGCGCTC CAGTCACCTC TCCCATCCCG GTGCCGTGGC 960
CGGGCCGTTC CCTGGAGAGT GGACGGCTGG GGCTGGTGCA GGGAACAGGG GCCTGCGGGG 1020
GCTGCGCAGG CGGGCCTCCA GGTCATGCGG GGCCCCTCTG CTCACAGGGA CCAGCCAGGC 1080
CAGCCTGGGG AGCGTGCTTC TTTGTTTATG TCTGTATTTC TCTGCCTATC TGTGGAAACC 1140
ACAGATCTCC AATTGAAGCC AACACCACAA GATTCATTCT GCTTCTCTCC GAGACGCCTG 1200
CCTGCCTGCC TTCCTTCCTT CCTTCCTCCC TCCCTTCCTC CCTTCTTCCC TTCCTTCCTT 1260
CACCAGGTTA TGAAAGTGGC TAATTTTTCA TATTTTTTGT AGAGACAGGG TTTCACCATG 1320
TTGCCAAGGC TGGTCTTGAA CTCCTGGGCT CAAGCGATTC ACCTGCCTTG GCCTCCCAAA 1380
GTGCTGGGAT TATTGGCATG AGACACCGAA CCTGGCCTTT TTTCTTTTGT CCCCCTTTTT 1440
TTTTTGAGAC AAGGTCTCAC CCTGTCGCCC AGGCTGGAGT CCCATGGCAT GATCTCAGCT 1500
CACTGTAGCC TTGAACTCCT GTATACAAGA GATCCTCCCA CCCCGGCCTC CAGAGTGTTA 1560
GGGTTGCAGG CCGAGCCACC ATGCCAGGCT GAGGCATCTT TCTAAGTGTC TTTGTTGAAA 1620
GTGAGAAGAC TGGCTTCCGT TACTCTCAAT ATGTTTATTT CTGTGATCAC CCTTTTGTAA 1680
TTAATCTCTG GTGTCCACCG CCCACTGTTA CCCAAGTGAA TGCATGCCTC TCCCCACCTG 1740
GGCTCCGACC CTGGCAGGGT TCCTTCTTGT CTTGTATGTC TGTCTCCCTC ACCCTACAGA 1800
CCCTGACTCC TGTGTCAGGC TGCCCTTTCT TGGGGACCCC TGTATCACCA TGCCTGGCCC 1860
TGATGCCTCT TGCCAGGGTG CCATTCTGTG GGAAGGCCCT CTGCACTGAG CTTGGGCACT 1920
GACATTCTGC CCTGGGCCCC TGCCTCACCA CTGTTACCCT GCACCTGCAC CTTGCTCTGC 1980
CCCGTCTAAT CTAGGACTGA ATTCTTCTGG GAGGGGAGAG GTTACATGTT CCCTGTCACT 2040
GGAATAACAG CTCTGGTGAT 2060